Carlyle »

Onkure Therapeutics Inc-a shares owned by Carlyle

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a shares owned by Carlyle from 13F filings

Historical chart of Carlyle investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Carlyle consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Carlyle

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.3M 270k 8.62

More positions owned by Carlyle

Standardaero
Soleno Therapeutics (SLNO)
Weride Sponsored Ads
Pony Ai Sponsored Ads
Phathom Pharmaceuticals (PHAT)
Jasper Therapeutics Com New (JSPR)
Getty Images Holdings Cl A Com (GETY)
Invitation Homes (INVH)
Cubesmart (CUBE)
Seacor Marine Hldgs (SMHI)
Forward Air Corporation (FWRD)
Exicure (XCUR)
Hillevax (HLVX)
Q32 Bio (QTTB)
Complete Solaria (CSLR)

View all positions for Carlyle

Top funds holding Onkure Therapeutics Inc-a

Cormorant Asset Management
Citadel Advisors
Perceptive Advisors
Samsara BioCapital
Vanguard Group
Vestal Point Capital
Deep Track Capital
StepStone
NEA Management Company
Highbridge Capital Management
Tang Capital Management
Carlyle
Ikarian Capital
Bank of America Corporation
Altium Capital Management

View all funds holding Onkure Therapeutics Inc-a